» Articles » PMID: 25740145

Circulating Nucleic Acids Damage DNA of Healthy Cells by Integrating into Their Genomes

Abstract

Whether nucleic acids that circulate in blood have any patho-physiological functions in the host have not been explored.We report here that far from being inert molecules, circulating nucleic acids have significant biological activities of their own that are deleterious to healthy cells of the body. Fragmented DNA and chromatin (DNAfs and Cfs) isolated from blood of cancer patients and healthy volunteers are readily taken up by a variety of cells in culture to be localized in their nuclei within a few minutes. The intra-nuclear DNAfs and Cfs associate themselves with host cell chromosomes to evoke a cellular DNA-damage-repair-response (DDR) followed by their incorporation into the host cell genomes. Whole genome sequencing detected the presence of tens of thousands of human sequence reads in the recipient mouse cells. Genomic incorporation of DNAfs and Cfs leads to dsDNA breaks and activation of apoptotic pathways in the treated cells. When injected intravenously into Balb/C mice, DNAfs and Cfs undergo genomic integration into cells of their vital organs resulting in activation of DDR and apoptotic proteins in the recipient cells. Cfs have significantly greater activity than DNAfs with respect to all parameters examined, while both DNAfs and Cfs isolated from cancer patients are more active than those from normal volunteers. All the above pathological actions of DNAfs and Cfs described above can be abrogated by concurrent treatment with DNase I and/or anti-histone antibody complexed nanoparticles both in vitro and in vivo. Taken together, our results suggest that circulating DNAfs and Cfs are physiological, continuously arising, endogenous DNA damaging agents with implications to ageing and a multitude of human pathologies including initiation of cancer.

Citing Articles

Copper Imparts a New Therapeutic Property to Resveratrol by Generating ROS to Deactivate Cell-Free Chromatin.

Khanvilkar S, Mittra I Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861193 PMC: 11769567. DOI: 10.3390/ph18010132.


An appropriate DNA input for bisulfite conversion reveals LINE-1 and Alu hypermethylation in tissues and circulating cell-free DNA from cancers.

Tran T, Pham T, Nguyen T, Hien Do T, Luu P, Nguyen U PLoS One. 2025; 19(12):e0316394.

PMID: 39775734 PMC: 11684646. DOI: 10.1371/journal.pone.0316394.


New light on chemotherapy toxicity and its prevention.

Juthani R, Punatar S, Mittra I BJC Rep. 2024; 2(1):41.

PMID: 39516565 PMC: 11524128. DOI: 10.1038/s44276-024-00064-8.


Tumor- and Fibroblast-Derived Cell-Free DNAs Differently Affect the Progression of B16 Melanoma In Vitro and In Vivo.

Filatova A, Alekseeva L, Senkova A, Savin I, Sounbuli K, Zenkova M Int J Mol Sci. 2024; 25(10).

PMID: 38791341 PMC: 11120878. DOI: 10.3390/ijms25105304.


Diversity of Intercellular Communication Modes: A Cancer Biology Perspective.

Ebrahim T, Ebrahim A, Kandouz M Cells. 2024; 13(6.

PMID: 38534339 PMC: 10969453. DOI: 10.3390/cells13060495.


References
1.
Pliss A, Malyavantham K, Bhattacharya S, Berezney R . Chromatin dynamics in living cells: identification of oscillatory motion. J Cell Physiol. 2012; 228(3):609-16. DOI: 10.1002/jcp.24169. View

2.
Wagstaff K, Fan J, De Jesus M, Tremethick D, Jans D . Efficient gene delivery using reconstituted chromatin enhanced for nuclear targeting. FASEB J. 2008; 22(7):2232-42. DOI: 10.1096/fj.07-099911. View

3.
Karolchik D, Barber G, Casper J, Clawson H, Cline M, Diekhans M . The UCSC Genome Browser database: 2014 update. Nucleic Acids Res. 2013; 42(Database issue):D764-70. PMC: 3964947. DOI: 10.1093/nar/gkt1168. View

4.
Sakurai T, Itoh K, Liu Y, Higashitsuji H, Sumitomo Y, Sakamaki K . Low temperature protects mammalian cells from apoptosis initiated by various stimuli in vitro. Exp Cell Res. 2005; 309(2):264-72. DOI: 10.1016/j.yexcr.2005.06.002. View

5.
Halicka H, Bedner E, Darzynkiewicz Z . Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp Cell Res. 2000; 260(2):248-56. DOI: 10.1006/excr.2000.5027. View